(2) The second reason that the increase of use is alarming is because of effects on patients access to their prescribed drugs
A recent poll has shown 1 in 8 people in the US are taking or have taken a GLP-1 medication
Incretin analogs, a class of neurohormones that act in a multimodal way, represent some of the most advanced options in anti-obesity pharmacotherapy
Frequently Asked Questions About Weight Loss Drugs Medically Reviewed By Frank Melo, MD Board Certified Addiction Medicine and Family Medicine Medical Director, Solstice Health & Wellness Last Updated: May 2026 References Elmaleh-Sachs A, Schwartz JL, Bramante CT, et al
The evolution of GLP-1s GLP-1 costs and utilization continue to rise
Patients showing robust response